The David H. Koch Institute for Integrative Cancer Research (/ˈkoʊk/ kohk; also referred to as the Koch Institute, KI, or CCR/KI) is a cancer research center affiliated with the Massachusetts Institute of Technology (MIT) located in Cambridge, Massachusetts, United States.
The Institute is one of eight National Cancer Institute-designated basic research centers in the United States.
The Institute was launched in October 2007 with a $100 million grant from David H. Koch and the 180,000 square feet (17,000 m2) research facility opened in December 2010, replacing the MIT Center for Cancer Research (CCR). The Institute is affiliated with 25 MIT faculty members in both the Schools of Engineering and Science.
The Latest Updated Research News:
Koch Institute for Integrative Cancer Research research articles from Innovation Toronto
- Real-Time Data for Cancer Therapy – August 9, 2015
- New material opens possibilities for super-long-acting pills
- Freshly squeezed vaccines
- How to identify drugs that work best for each patient
- New nanogel for drug delivery
- New drug-delivery capsule may replace injections
- Engineering new bone growth
- Targeting cancer with a triple threat
- A paper diagnostic for cancer
- Pills of the future: nanoparticles
- VIDEO: Better batteries through biology?
- Nanoparticle vaccine offers better protection
- Researchers figure out why gold nanoparticles can penetrate cell walls
- Injectable ‘Smart Sponge’ Holds Promise for Controlled Drug Delivery
- A step closer to artificial livers
- A safer way to vaccinate
- VIDEO: New material harvests energy from water vapor
- New technology may enable earlier cancer diagnosis
- Inspiration from a porcupine’s quills
- VIDEO: Getting (drugs) under your skin
- Researchers grow cyborg tissues with embedded nanoelectronics
- First Targeted Nanomedicine to Enter Human Clinical Studies
- Antibody offers hope against cancers
- Why This E. Coli Outbreak Has Me Scared